Skip to main content
. Author manuscript; available in PMC: 2006 Jun 11.
Published in final edited form as: J Am Coll Cardiol. 2005 Dec 13;47(1):45–51. doi: 10.1016/j.jacc.2005.04.071

Table 3.

Hospital characteristics and improvement*

Fibrinolytic Therapy Cohort
PCI Cohort
minutes/year p minutes/year p
Average −0.01 0.956 −0.58 0.094
Geographic location >.500 0.046
 New England 0.2 −7.5
 Middle Atlantic 0.2 0.8
 South Atlantic 0.3 −0.5
East North Central −0.3 −0.5
 East South Central 0.1 −0.7
 West North Central −0.5 −1.6
 West South Central 0.3 0.4
 Mountain −0.2 1.1
 Pacific 0.0 −0.6
Ownership 0.152 0.329
 Public −0.2 0.8
 Not-for-profit −0.1 −0.6
 Private 0.8 −1.6
Teaching >.500 >.500
 Urban/teaching 0.1 −0.6
 Urban/nonteaching 0.2 −0.3
 Rural/teaching 0.2 −1.7
 Rural/nonteaching −0.1 −3.1
Facilities >.500 0.271
 Open-heart surgery program 0.3 −0.5
 Cardiac catheterization lab only −0.2 −1.9
 Other −0.1
Annual volume >.500 0.016
 <20 LYS or <15 PCI 0.1 1.0
 20-40 LYS or 15-50 PCI 0.0 −0.1
 >40 LYS or >50 PCI 0.0 −1.9
Reperfusion specialization 0.086 0.294
 %LYS or %PCI <20% 6.0 −2.3
 %LYS or %PCI 20%-90% 0.6 −0.4
 %LYS or %PCI > 90% −0.3 −1.9
*

Adjusted for patient characteristics (from Table 1)

LYS=fibrinolytic therapy; PCI=percutaneous coronary intervention